Rod and Cone Dystrophy Treatment With Stem Cell Therapy

Genetic abnormalities affecting the cone photoreceptor cells in the retina cause dystrophy, and current research has identified about 35 genes that are involved in these alterations. A slow loss of vision results from this genetic mutation, which causes these cells to gradually degenerate. Globally, these illnesses are thought to impact 1 in 20,000 to 100,000 people. There are two primary types of eye injuries: minor injuries are typically brought on by exposure to substances like smoke, soap, and dust, while major injuries are typically the result of eye-related incidents.

Giving patients access to the finest available therapies, treatments, and drugs helps. Because of their vital significance in our daily lives and cognitive processes, maintaining the health of our eyes is still very important. Even if treating Rod dystrophy could be difficult or impossible, ongoing attempts are still necessary. It is the duty of medical professionals to investigate all possible options for improving visual abilities or restoring vision.

Rod and cone stem cell treatment:

Stem Cell Utilization Modern facilities offering cutting-edge therapies for Rod and Cone diseases are provided at Rod and Cone Dystrophy, removing the need for patients to travel overseas for care. To guarantee patients receive the best care possible, these facilities place a high priority on state-of-the-art equipment and maintain strict hygienic standards.

If treatment for Rod and Cone’s illnesses is delayed, there is a chance that eyesight will be lost. Because these hereditary disorders are directly related to genes, there are currently few effective treatments available. Stem cell treatment, on the other hand, shows promise because it attempts to repair the damaged photoreceptor cells, halt future degradation, and promote long-term eye health.

The strategy makes use of mesenchymal stem cells injected by “Retro-bulbar” injections, a very safe and efficient method. With this technique, the regeneration of defective or injured retinal photoreceptor cells is maximized. In addition to using Rod and Cone dystrophies, the Eye Stem Cell Centre also treats diabetic retinopathy, macular degeneration, and Stargardt’s/Macular Dystrophy.

Damage to the retina’s blood vessels results from diabetic retinopathy, a disorder linked to high blood sugar levels.

In order to prevent these issues, the Eye Stem Cell Centre addresses this issue and emphasizes how crucial blood sugar management is. The Center seeks to stop or lessen the harmful effects of diabetic retinopathy by making cellular interventions.

The available treatment plans concentrate on the regeneration of photoreceptor cells while offering individualized attention based on the patient’s condition. By utilizing the body’s regenerative ability to maintain ocular health and restore eyesight over time, stem cell therapy offers a viable remedy. The Center works to treat different retinal disorders by using a holistic strategy and specialized procedures. It provides patients with vision-related illnesses with hope and an enhanced quality of life.

Promising opportunities exist for treating these problems with stem cell treatment in India, which aims to repair damaged photoreceptor cells linked to Rod and Cone diseases in order to restore eyesight. By stopping the continued deterioration of these cells, this treatment hopes to restore ocular health and promote long-term, sustained eye regeneration.